MedTrace Logo

BIS Monitoring in Relation to Muscle Relaxant Administration

NCT05440058 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2023-10-13

No results posted yet for this study

Summary

The purpose of this study is to determine the overall optimal timing of when the Bispectral Index (BIS) monitor should be started: before or after the muscle relaxant is given.

Conditions

  • Cardiovascular Surgery
  • Bispectral Index
  • Anesthesia

Interventions

DEVICE

Bispectral Index (BIS) monitoring system

Left and right sensors to record EEG activity and muscle reaction to anesthesia utilized in the operating room by anesthesia providers to assess the depth of sedation in patients with anesthesia.

Sponsors & Collaborators

Principal Investigators

  • Matthew Ritter, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-26
Primary Completion
2022-09-20
Completion
2022-09-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05440058 on ClinicalTrials.gov